Regular Plan · IDCW · Index Funds · Scheme code 150931
NAV₹20.0420as on 28 Oct 2026
Fund houseICICI Prudential Mutual Fund
CategoryIndex Funds
Plan & optionRegular · IDCW
History3.7 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
2.29
10.91
17.29
23.10
20.48
—
—
—
21.46
Nifty 100 benchmark
0.25
3.49
-1.52
1.84
10.52
9.38
—
—
12.79
Index Funds category median
—
—
—
-3.89
7.27
5.88
—
10.77
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
15.9%
0.88
1.47
0.66
11.44%
-16.8%
35.81
Nifty 100 benchmark
14.4%
0.28
0.40
—
—
-37.0%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
36 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
667
-9.0%
14.4%
62.0%
12%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
112%
54%
0.60
13.7%
0.74
21.33
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 36 months this scheme and
Nifty 100 share.
ICICI Prudential Nifty Pharma Index Fund
Regular Plan · IDCW
Allocation
By asset
Equity
99.94%
Cash & Equivalents
0.06%
By market cap
Large Cap
46.31%
Mid Cap
46.08%
Small Cap
7.55%
Concentration
Number of stocks
20
Top 5 stocks
54.59%
Top 10 stocks
78.15%
Top 20 stocks
99.94%
Lines in the filing
22
Largest holding
19.50%
Largest sector
Pharmaceuticals & Biotechnology 99.94%
Effective stocks
11.5
Sectors held
1
Cash
0.06%
Effective stocks is what the concentration works out to: a fund holding
20 names but most of its money in a few
behaves like a fund of 12. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Pharmaceuticals & Biotechnology
99.94%
Cash & Equivalents
0.06%
ICICI Prudential Nifty Pharma Index Fund
Regular Plan · IDCW · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
175,082
32
19.50%
2
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
21,013
20
11.97%
3
Laurus Labs Ltd.
Pharmaceuticals & Biotechnology
64,400
13
7.82%
4
Cipla Ltd.
Pharmaceuticals & Biotechnology
93,053
13
7.68%
5
Dr. Reddy's Laboratories Ltd.
Pharmaceuticals & Biotechnology
100,842
12
7.62%
6
Torrent Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
24,332
12
7.16%
7
Lupin Ltd.
Pharmaceuticals & Biotechnology
40,165
8
5.00%
8
Aurobindo Pharma Ltd.
Pharmaceuticals & Biotechnology
45,698
8
4.68%
9
Glenmark Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
24,895
6
3.56%
10
Alkem Laboratories Ltd.
Pharmaceuticals & Biotechnology
9,970
5
3.16%
11
Zydus Lifesciences Ltd.
Pharmaceuticals & Biotechnology
40,975
5
2.92%
12
Mankind Pharma Ltd.
Pharmaceuticals & Biotechnology
18,737
5
2.88%
13
IPCA Laboratories Ltd.
Pharmaceuticals & Biotechnology
22,971
4
2.71%
14
Biocon Ltd.
Pharmaceuticals & Biotechnology
115,240
4
2.62%
15
Gland Pharma Ltd.
Pharmaceuticals & Biotechnology
13,178
4
2.34%
16
Sai Life Sciences Ltd.
Pharmaceuticals & Biotechnology
22,870
3
2.14%
17
Wockhardt Ltd.
Pharmaceuticals & Biotechnology
13,659
3
1.77%
18
Ajanta Pharma Ltd.
Pharmaceuticals & Biotechnology
7,537
3
1.67%
19
TREPS
Unclassified
—
2
1.50%
20
Abbott India Ltd.
Pharmaceuticals & Biotechnology
861
2
1.43%
21
Piramal Pharma Ltd.
Pharmaceuticals & Biotechnology
102,715
2
1.30%
ICICI Prudential Nifty Pharma Index Fund
Regular Plan · IDCW · where the money sits
What the manager did last month
Between the filings of 31 Mar 2026 and 31 Jul 2026.
A position grows because the manager bought or because the price rose; only the share count separates them.
Bought
Sold
New positions
Sold out of
Price move of holdings
₹23 cr
₹0 cr
1
1
+22.55%
Stock
Shares traded
Shares
Price
Value ₹ cr
New position
Sai Life Sciences Ltd.
20,658
entered
—
2.7
Added to
Sun Pharmaceutical Industries Ltd.
22,237
+16.3%
+13.3%
4.4
Torrent Pharmaceuticals Ltd.
8,495
+63.1%
+21.4%
4.4
Divi's Laboratories Ltd.
2,665
+16.3%
+35.5%
2.2
Cipla Ltd.
11,822
+16.3%
+20.3%
1.7
Laurus Labs Ltd.
8,165
+16.3%
+83.0%
1.5
Dr. Reddy's Laboratories Ltd.
12,820
+16.3%
-8.5%
1.5
Lupin Ltd.
5,136
+16.5%
+4.4%
1.2
Aurobindo Pharma Ltd.
5,456
+15.2%
+21.1%
0.9
Sold out of
J.B.Chemicals & Pharmaceuticals Ltd.
10,539
exited
—
2.2
Not equity
Previous filing
This filing
Change
Cash, repo and TREPS
₹0 cr
₹0 cr
+₹0 cr
The list above is stocks and fund units. Treasury bills, repo and money-market
lines roll over every month by design — they are not decisions, so they are totalled here rather
than listed as activity.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 30 Oct 2026.
